Inactive Instrument

News Eleven Biotherapeutics Inc Nasdaq

Equities

US2862211065

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference	07:31am	PR
Carisma Therapeutics : Corporate Presentation May 2024	May. 02	PU
Carisma Therapeutics : Corporate Presentation May 2024	May. 02	PU
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer	May. 02	PR
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer	May. 02	CI
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy Annual Meeting	Apr. 23	AQ
BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target	Apr. 11	MT
Carisma Therapeutics to Present at Upcoming Conferences	Apr. 03	PR
HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating	Apr. 02	MT
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	Apr. 02	AQ
Carisma Therapeutics Q4 Net Loss Narrows, Revenue Rises; Plans Job Cuts in Q2 -- Shares Decline	Apr. 01	MT
Carisma Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Carisma Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
Carisma Therapeutics Announces Changes to its Board of Directors	Apr. 01	PR
Carisma Therapeutics, Inc. Announces Changes to Its Board of Directors	Apr. 01	CI
North American Morning Briefing : Stock Futures -2-	Mar. 19	DJ
North American Morning Briefing : Inflation Data -2-	Mar. 12	DJ
Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference	Feb. 28	PR
Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Dec. 21	PR
Carisma Therapeutics' First Lead Candidate Under Moderna Deal to Target Cancer Treatment	Dec. 14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Eleven Biotherapeutics Inc Nasdaq

Equities

US2862211065

Summary

Filters